It’s time for another edition of the Reading Roundup featuring the top blog posts from January 2017. Start off your weekend by kicking back and catching up on what the pharmaceutical industry was reading in January.
View the articles from Pharmaceutical Engineering® magazine that made the cut for the 2016 Article of the Year Award. Winning article will be announced on Thursday, February 2.
According to a team presenting during the Continuous Processing session at the 2016 ISPE Biopharmaceutical Manufacturing Conference the answer is a resounding “yes, but”! Andre Walker, CPIP, Principal, Andre Walker Consulting, led this session that debated whether continuous processing could transform the economics of the highly regulated pharmaceutical industry as it did industries from steel to petroleum; and in particular whether the unique nature of biopharmaceutical products represent an insurmountable challenge. Read more to find out what came out of the debate, and if Continuous Biopharmaceutical Manufacturing can live up to the hype.
Watch the video from Line Lunsberg-Nielson, Principal Consultant, NNE Pharmaplan, as she shares the key takeaways of ISPE’s Process Validation training course.
This “first of its kind” document addresses an issue that has been costing the pharmaceutical industry millions of dollars every year and learn more about how it can help your company start saving money today.
Regulatory authorities worldwide employ different terminologies to describe various medicinal and health products. Learn how this is impacting the health supplements market and what regulatory authorities are doing to get a grasp on this rapidly growing market.
The following blog post was provided by Peyton Myers, an undergraduate student at Appalachian State University. Myers attended the 2023 ISPE Annual Meeting & Expo in Las Vegas as an ISPE Foundation Professional Development Grant recipient.
The integration of data science in biopharmaceutical manufacturing, emphasizing data quality, tech transfer efficiency, and process optimization, is the heart of this track. Led by industry experts, discussions explore leveraging digital twins, predictive analytics, and continuous improvement initiatives. Additionally, interactive roundtable discussions provide attendees with a dynamic forum...
The pharmaceutical sector stands at a crossroads of immense possibilities. We are witnessing an unprecedented surge in innovation, fueled by a remarkable partnership between industry and regulatory authorities. For example, there are initiatives fostered by the US Food and Drug Administration (US FDA) to promote innovation with programs such as CATT (CBER Advanced Technologies Team) and ETP...
